以质量求发展,以服务铸品牌

护理学报 ›› 2023, Vol. 30 ›› Issue (13): 42-46.doi: 10.16460/j.issn1008-9969.2023.13.042

• 循证护理 • 上一篇    下一篇

精准医学背景下母方案设计临床应用的范围综述

叶琴1, 周立霞2, 刘宁1   

  1. 1.遵义医科大学珠海校区 护理学系,广东 珠海 519041;
    2.遵义医科大学附属第五(珠海)医院 肿瘤科,广东 珠海 519041
  • 收稿日期:2023-04-03 出版日期:2023-07-10 发布日期:2023-08-04
  • 通讯作者: 刘宁(1981-),女,陕西西安人,博士,教授,博士研究生导师,南方医院JBI循证护理合作中心导师库成员。E-mail:761066906@qq.com
  • 作者简介:叶琴(1996-),女,贵州遵义人,本科学历,硕士研究生在读,护师。
  • 基金资助:
    国家自然科学基金(82260281)

Clinical application of master protocol design in precision medicine: a scoping review

YE Qin1, ZHOU Li-xia2, LIU Ning1   

  1. 1. Department of Nursing, Zhuhai Campus, Zunyi Medical University, Zhuhai 519041, China;
    2. Dept. of Oncology, the Fifth Affiliated Hospital, Zunyi Medical University, Zhuhai 519041,China
  • Received:2023-04-03 Online:2023-07-10 Published:2023-08-04

摘要: 目的 全面检索国内外母方案设计的相关研究,了解其临床应用所覆盖的研究领域,为国内护理人员开展母方案设计相关研究的实施和推广提供参考。方法 采用Arksey和O'Malley提出的范围综述方法,系统检索中国知网、万方数据库、中国生物医学文献数据库、维普、PubMed、Cochrane Library、Embase、Web of Science,检索时限为从建库至2023年4月。根据纳入、排除标准筛选文献,2名研究者独立提取母方案设计核心要素及其应用领域相关资料,采用描述性分析及主题分析法对提取结果进行整理。结果 共纳入104篇文献,研究领域涉及肿瘤、临床心理学、新型冠状病毒肺炎等的药物开发评估及个性化健康计划的制定。母方案在国内外应用存在着明显差异,主要体现在3个方面:(1)应用范围不同,国外主要用于评估新药、疗法或医学器材的有效性和安全性,而在我国广泛应用于中医药领域;(2)研究类型有别,国外主要应用多中心随机对照试验、队列研究,而我国此类型研究相对较少;(3)经验和技术支持方面,由于历史和文化背景等原因,国外研究者在母方案的设计和实施方面拥有更丰富的经验和技术支持。因此,在推广和应用母方案时,需充分考虑国内外的差异,并结合本土实际情况探索出适合自身条件下的研究模式和方法,以推进其更广泛和深入的应用。结论 母方案的实施是临床研究模式的一次突破性创新,当前母方案设计的应用多集中在肿瘤学、新型冠状病毒肺炎领域,但伞式试验和篮式试验可用于健康领域,平台试验的范围可应用于临床心理学和数字心理健康干预,国内护理研究者应重视对母方案设计的应用,在其指导下开展相关研究,提升护士创新行为,积极寻找新方法和技术,循证优化试验设计,解决临床护理问题,快速适应精准医学的发展。

关键词: 母方案, 篮式试验, 伞式试验, 平台试验, 精准医学, 范围综述

Abstract: Objective To conduct a comprehensive search on studies regarding master protocols design at home and abroad, to understand the research fields in clinical application, and to provide reference for the implementation and promotion of the research about master protocol design by domestic nursing staff. Methods The scoping review proposed by Arksey and O'Malley was used, and we systematically searched literature in databases of CNKI, Wanfang Database, China Biomedical Literature Database, VIP Database, PubMed, Cochrane Library, Embase,and Web of science from the inception to April 2023. According to the inclusion and exclusion criteria, two researchers independently extracted the core elements of master protocol design and its application, and descriptive analysis and thematic analysis were used to sort out the data. Results A total of 104 pieces of literature were collected, covering oncology, psychology, traditional Chinese medicine, neurology, COVID-19 and drug development evaluation. There were significant differences in the application of master protocols between China and foreign countries, which can be mainly reflected in three aspects. 1) Different application scopes. In foreign countries master protocols were mainly used to evaluate the effectiveness and safety of new drugs, therapies or medical equipment, while in China it was widely applied to traditional Chinese medicine. 2) Different types of research. Multi-center randomized controlled trials and cohort studies were commonly used in foreign countries, while there was relatively less such research in China; 3) Differences in experience and technical support. Richer experience and technical support in the design and implementation of master protocols due to historical and cultural background were observed in foreign countries. Therefore, when promoting and applying master protocols, it was necessary to fully consider the differences between China and foreign countries, and explore suitable research models and methods that fit the local conditions, so as to promote the wider and deeper application. Conclusion The implementation of the master protocols is a breakthrough innovation of the clinical research. At present, the application of master protocols is mainly concentrated in the field of oncology and COVID-19, but the umbrella trial and basket trial can be used in the health field, and the platform trial can be applied to clinical psychology and digital mental health intervention. Domestic nursing researchers should pay attention to the application of master protocols and carry out researches under its guidance to optimize the trial design to adapt to the development of precision medicine.

Key words: master protocol, basket trial, umbrella trial, platform trial, precision medicine, scoping review

中图分类号: 

  • R197.323.6
[1] Subbiah V.The next generation of evidence-based medicine[J]. Nat Med, 2023,29(1):49-58. DOI:10.1038/s41591-022-02160-z.
[2] Redman MW, Allegra CJ.The master protocol concept[J]. Semin Oncol,2015,42(5):724-730.DOI:10.1053/j.seminoncol.2015.07.009.
[3] Di Liello R, Piccirillo MC, Arenare L, et al.Master protocols for precision medicine in oncology: overcoming methodology of randomized clinical trials[J]. Life (Basel), 2021,11(11):1253. DOI: 10.3390/life11111253.
[4] Woodcock J, LaVange LM.Master protocols to study multiple therapies, multiple diseases,or both[J]. N Engl J Med, 2017,377(1):62-70. DOI:10.1056/NEJMra1510062.
[5] 于亚南,杜培艳,刘骏,等. 精准医学创新性临床试验设计“主方案”研究的概念、设计与案例[J]. 中国新药杂志,2020, 29(23):2712-2717.DOI:10.3969/j.issn.1003-3734.2020.23.014.
[6] Arksey H, O'Malley L. Scoping studies: towards a methodological framework[J]. Int J Soc Res Method, 2005, 8(1): 19-32. DOI:10.1080/1364557032000119616.
[7] Aromataris E, Riitano D.Constructing a search strategy and searching for evidence. A guide to the literature search for a systematic review[J]. Am J Nurs, 2014,114(5):49-56. DOI: 10.1097/01.NAJ.0000446779.99522.f6.
[8] Liu W, Zhou L, Feng L, et al.BuqiTongluo granule for ischemic stroke, stable angina pectoris, diabetic peripheral neuropathy with Qi deficiency and blood stasis syndrome: rationale and novel basket design[J]. Front Pharmacol, 2021(12):764669. DOI: 10.3389/fphar.2021.764669.
[9] Lamb JJ, Stone M, D'Adamo CR, et al. Personalized lifestyle intervention and functional evaluation health outcomes survey: presentation of the LIFEHOUSE study using N-of-one tent-umbrella-bucket design[J]. J Pers Med, 2022,12(1):115. DOI: 10.3390/jpm12010115.
[10] Millen GC, Yap C.Adaptive trial designs: what are multiarm, multistage trials?[J]. Arch Dis Child Educ Pract Ed, 2020,105(6):376-378.DOI:10.1136/archdischild-2019-317826.
[11] 关之玥,刘岩,张晶晶,等. 母方案平台试验设计方法及其在相关领域中的应用[J]. 中国循证医学杂志,2021,21(8):986-992. DOI:10.7507/1672-2531.202104005.
[12] Gold, S, Bofill Roig, M, Miranda, J, et al. Platform trials and the future of evaluating therapeutic behavioural interventions[J]. Nat Rev Psychol, 2022,1(1):7-8. DOI:10.1038/s44159-021-00012-0.
[13] Werner-Seidler A, Hitchcock C, Bevan A, et al.A cluster randomized controlled platform trial comparing group memory specificity training (MEST) to group psychoeducation and supportive counselling (PSC) in the treatment of recurrent depression[J]. Behav Res Ther, 2018(105):1-9. DOI: 10.1016/j.brat.2018.03.004.
[14] Wells A, Fisher P, Myers S, et al.Metacognitive therapy in treatment-resistant depression: a platform trial[J]. Behav Res Ther,2012,50(6):367-373. DOI:10.1016/j.brat.2012.02.004.
[15] Dickson D, Johnson J, Bergan R, et al.The master observational trial: a new class of master protocol to advance precision medicine[J]. Cell, 2020,180(1):9-14. DOI:10.1016/j.cell.2019.12.009.
[16] Renfro LA, Sargent DJ.Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples[J]. Ann Oncol, 2017,28(1):34-43. DOI:10.1093/annonc/mdw413.
[17] Hyman DM, Solit DB, Arcila ME, et al.Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials[J]. Drug Discov Today, 2015,20(12):1422-18. DOI:10.1016/j.drudis.2015.08.005.
[18] 赵晨,张晓雨,胡嘉元,等. 中医同证候系疾病临床研究母方案设计方法[J]. 中医杂志, 2018,59(2):111-115. DOI:10.13288/j.11-2166/r.2018.02.006.
[19] 陈莹, 常静玲, 代恒恒, 等. 精准医学模式下的母方案篮式试验设计方法及其在中医药领域中的应用[J]. 中国循证医学杂志, 2022, 22(4):483-489.
[20] 高珺,苏丽文,袁鹰,等. 抗肿瘤药物主方案试验设计进展及统计考量[J].中国卫生统计, 2021,38(6):950-955. DOI:10.3969/j.issn.1002-3674.2021.06.035.
[21] Angus DC, Berry S, Lewis RJ, et al.The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. rationale and design[J]. Ann Am Thorac Soc, 2020,17(7):879-891. DOI: 10.1513/AnnalsATS.202003-192SD.
[1] 李垚, 陈小敏, 夏敏, 吴茜, 张琳, 陈叡喆, 葛莉丽, 吴逸梅. 肿瘤患者衰弱评估工具应用的范围综述[J]. 护理学报, 2025, 32(4): 48-52.
[2] 陈恩琳, 莫丰菱, 庄泽明, 张明哲, 周佳坤, 黄丽芳, 纪龙飞, 张莉芳. 脑卒中单侧空间忽略评估工具的范围综述[J]. 护理学报, 2025, 32(3): 43-49.
[3] 朱天顺, 朱可可, 薛会元, 焦聪聪, 魏长慧, 王贺. 信息框架效应理论在健康管理领域应用的范围综述[J]. 护理学报, 2025, 32(2): 44-49.
[4] 李珂, 贺雨琼, 李雨蔚, 常颖. 脑卒中患者跌倒恐惧干预研究的范围综述[J]. 护理学报, 2025, 32(1): 50-55.
[5] 李丁丁, 王帅有, 朱杉杉, 郭鑫, 张会敏, 王宏茹, 潘勤. 脑卒中患者支持性照护需求评估工具的范围综述[J]. 护理学报, 2024, 31(9): 48-53.
[6] 梅紫琦, 金胜姬, 李玮彤, 柏亚妹, 宋玉磊, 李伊婷, 王萌, 徐桂华. 智能机器人在护理健康教育领域中应用的范围综述[J]. 护理学报, 2024, 31(7): 57-62.
[7] 郭俊晨, 刘超毅, 戴云云, 蒋思珊, 杨索, 谌永毅. 虚拟现实技术在生命末期患者中应用的范围综述[J]. 护理学报, 2024, 31(7): 40-45.
[8] 郑晓婷, 田霞, 王峥, 肖文莉. King达标理论在慢性病家庭护理中应用的范围综述[J]. 护理学报, 2024, 31(5): 56-60.
[9] 李佳萍, 朱云霞, 朱宇. 乳腺癌化疗患者症状群的范围综述[J]. 护理学报, 2024, 31(4): 60-64.
[10] 李伟, 王香, 裴丽, 高擎擎, 黄海超. 妊娠晚期孕妇症状群的范围综述[J]. 护理学报, 2024, 31(3): 51-56.
[11] 王月, 刘国庆, 牛聪影, 张振伟, 孙建, 褚友艾, 秦寒枝. 髋部骨折患者术后30天死亡风险预测模型的范围综述[J]. 护理学报, 2024, 31(24): 51-56.
[12] 王爱, 周冰倩, 曹虹. 骨折联络服务在骨质疏松性髋部骨折患者中应用的范围综述[J]. 护理学报, 2024, 31(22): 48-53.
[13] 吴萍, 于宛辰, 柳嘉怡, 王汕珊, 胡燕. 糖尿病前期人群社会支持研究的范围综述[J]. 护理学报, 2024, 31(21): 49-54.
[14] 郭世鸿, 柏晓玲, 楼婷, 余娜, 杨曾桢, 牛雨田, 李慧. 口腔衰弱评估工具的范围综述[J]. 护理学报, 2024, 31(14): 52-56.
[15] 邓颖一, 程露颖, 龚喜燕, 王敏, 廖冬霞, 张翠翠, 丁娟, 古清鹭, 廖常菊. 临床护理交接班循证实践的范围综述[J]. 护理学报, 2024, 31(14): 57-62.
Viewed
Full text


Abstract

Cited

  Shared   
No Suggested Reading articles found!